Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: ePlus Q1 Earnings

ePlus (NASDAQ:PLUS) reported its Q1 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings ePlus beat estimated earnings by 1.02%, reporting an EPS of $0.99 versus an estimate of $0.98.
byBenzinga Insights
August 3, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

ePlus (NASDAQ:PLUS) reported its Q1 earnings results on Wednesday, August 3, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

ePlus beat estimated earnings by 1.02%, reporting an EPS of $0.99 versus an estimate of $0.98.

Revenue was up $41.71 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.33 which was followed by a 2.24% increase in the share price the next day.

 

To track all earnings releases for ePlus visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Orthopedic Devices Maker Treace Medical Concepts’ Gloomy Forecast Cast Concerns Over Long-Term Viability

By Vandana Singh
May 8, 3:08 PM
Treace Medical Concepts reports Q1 EPS loss of $(0.30), sales hit $51.11 million, up 21%. Surge in procedure kits sold due to expanded surgeon base and product mix shift. FY24 sales guidance adjusted to $201M-$211M. Analysts downgrade, citing competitive challenges.

TMCI